Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityNo recent work listed

Bingyuan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8989-1791; OpenAlex author ID A5009096025. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Co-author DOI 10.1016/j.omtn.2021.06.001↗
  2. Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway. Co-author DOI 10.1038/s41419-018-0724-5↗
  3. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1. Last author DOI 10.1159/000485876↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanxiang Zhan · 2 shared papers, 2017–2021 · strength 0.18
  2. Jian Yang · 1 shared paper, 2021 · strength 0.12
  3. Sanyuan Hu · 1 shared paper, 2021 · strength 0.12
  4. Bin Zhou · 1 shared paper, 2021 · strength 0.12
  5. Yongzheng Li · 1 shared paper, 2021 · strength 0.12
  6. Zhaowei Sun · 1 shared paper, 2021 · strength 0.12
  7. Yunshan Wang · 1 shared paper, 2021 · strength 0.12
  8. Zhiyao Fan · 1 shared paper, 2021 · strength 0.12
  9. Weidong Guo · 1 shared paper, 2018 · strength 0.11
  10. Bin Zhou · 1 shared paper, 2018 · strength 0.11
  11. Fang Zheng · 1 shared paper, 2018 · strength 0.11
  12. Bin Zhou · 1 shared paper, 2017 · strength 0.07
  13. Xiao Hu · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.